NBY Aset Bersih saben Siji Saham novabay.com

Partnerships with pharmacy chains and ophthalmologists are driving sales, as illustrated by the equity per share chart, where the latest mark stands at -2.24. NovaBay Pharmaceuticals (NBY) is creating unique Avenova antimicrobial formulations by investing in safe formulas. Diversified warehouse hubs in the US bolster business stability, completely eliminating component supply disruptions.

NBY (NovaBay) riwayat Nilai Akuntansi Saham saka 04.07.2022 nganti 18.04.2026

Rincian analitis perusahaan NovaBay Pharmaceuticals Inc. (NBY)

- rega saham lan prakiraan rega para ahli:

Kutipan saham NovaBay|NBY - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar NovaBay Pharmaceuticals, Inc.|NBY - Nilai Wutuh Bisnis

- data nilai buku modal saham:

Nilai Buku saben Saham NovaBay Pharmaceuticals|NBY - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku novabay.com|NBY - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Ekuitas NovaBay Pharmaceuticals|NBY - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas NovaBay|NBY - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku NovaBay Pharmaceuticals, Inc.|NBY - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan NovaBay Pharmaceuticals|Rasio cepet novabay.com

- indikator pendapatan resik lan kelipatan nilai:

NBY - Penghasilan resik perusahaan

Analisis wiwitan perusahaan:novabay.com (NBY)

Book value per share reflects the portion of net assets attributable to a single security, allowing an investor to assess the intrinsic value of the business net of all liabilities. The trend in book value per share confirms the capitalization of NovaBay Pharmaceuticals (NBY), which is growing through the implementation of energy-efficient ESG standards and the optimization of production chains within the ophthalmology sector.

Pesaing NovaBay Pharmaceuticals (NBY)